Intestinal inflammation caused by anti-cancer drugs is ameliorated by ginsenoside

被引：0
|
作者：
Tsujii, Taisei
Kato, Daisuke
Jonan, Shizuka
Amagase, Kikuko
机构：
来源：
PHYSIOLOGY | 2023年 / 38卷
关键词：
D O I：
10.1152/physiol.2023.38.S1.5734772
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF ANTI-CANCER DRUGS IN CHILDREN
    EVANS, WE
    CROM, WR
    SINKULE, JA
    YEE, GC
    STEWART, CF
    HUTSON, PR
    DRUG METABOLISM REVIEWS, 1983, 14 (05) : 847 - 886
  • [42] Liposomal encapsulated anti-cancer drugs
    Hofheinz, RD
    Gnad-Vogt, SU
    Beyer, U
    Hochhaus, A
    ANTI-CANCER DRUGS, 2005, 16 (07) : 691 - 707
  • [43] Taxanes: Promising Anti-Cancer Drugs
    Fauzee, Nilufer Jasmine Selimah
    Dong, Zhi
    Wang, Ya-lan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 837 - 851
  • [44] Tissue transport of anti-cancer drugs
    Lankelma, J
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (22) : 1987 - 1993
  • [45] Anaesthesia and anti-cancer chemotherapeutic drugs
    Huettemann, Egbert
    Sakka, Samir G.
    CURRENT OPINION IN ANESTHESIOLOGY, 2005, 18 (03) : 307 - 314
  • [46] Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes
    Moku, Gopikrishna
    Gulla, Suresh Kumar
    Nimmu, Narendra Varma
    Khalid, Sara
    Chaudhuri, Arabinda
    BIOMATERIALS SCIENCE, 2016, 4 (04) : 627 - 638
  • [47] ANTI-BACTERIAL ACTIVITY OF ANTI-CANCER DRUGS
    GEMMELL, CG
    HARDING, NGL
    JOURNAL OF MEDICAL MICROBIOLOGY, 1981, 14 (02) : R7 - R8
  • [48] Targeting Cancer Metabolism and Current Anti-Cancer Drugs
    Sukjoi, Witchuda
    Ngamkham, Jarunya
    Attwood, Paul V.
    Jitrapakdee, Sarawut
    REVIEWS ON NEW DRUG TARGETS IN AGE-RELATED DISORDERS, PT II, 2021, 1286 : 15 - 48
  • [49] Cancer Cell Models for the Development of Anti-Cancer Drugs
    Telang, Nitin T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [50] MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
    Pennati, Marzia
    Folini, Marco
    Gandellini, Paolo
    Zaffaroni, Nadia
    CURRENT DRUG TARGETS, 2016, 17 (03) : 257 - 265
12345